Mitchell Austin Rudy Buys 12,000 Shares of Bonk (NASDAQ:BNKK) Stock

Bonk, Inc. (NASDAQ:BNKKGet Free Report) Director Mitchell Austin Rudy acquired 12,000 shares of the business’s stock in a transaction on Wednesday, June 10th. The stock was acquired at an average price of $1.37 per share, with a total value of $16,440.00. Following the acquisition, the director owned 63,341 shares in the company, valued at $86,777.17. The trade was a 23.37% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link.

Mitchell Austin Rudy also recently made the following trade(s):

  • On Thursday, April 9th, Mitchell Austin Rudy purchased 31,055 shares of Bonk stock. The stock was purchased at an average cost of $2.82 per share, with a total value of $87,575.10.

Bonk Stock Performance

Shares of Bonk stock traded down $0.03 during mid-day trading on Tuesday, hitting $1.33. The stock had a trading volume of 125,977 shares, compared to its average volume of 417,288. The firm has a 50-day moving average of $2.21 and a two-hundred day moving average of $3.18. Bonk, Inc. has a 12-month low of $1.25 and a 12-month high of $46.90.

Bonk (NASDAQ:BNKKGet Free Report) last posted its quarterly earnings results on Wednesday, May 13th. The company reported ($0.23) earnings per share for the quarter. Bonk had a negative net margin of 838.37% and a negative return on equity of 148.62%. The firm had revenue of $0.79 million during the quarter.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on BNKK. Weiss Ratings cut shares of Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, April 29th. Wall Street Zen raised shares of Bonk from a “sell” rating to a “hold” rating in a research report on Saturday. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Bonk presently has an average rating of “Sell”.

Get Our Latest Stock Report on Bonk

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. State Street Corp acquired a new position in Bonk in the fourth quarter valued at $33,000. Steward Partners Investment Advisory LLC acquired a new stake in shares of Bonk in the fourth quarter valued at approximately $37,000. Jane Street Group LLC acquired a new stake in shares of Bonk in the fourth quarter valued at approximately $96,000. Finally, Geode Capital Management LLC acquired a new stake in shares of Bonk in the fourth quarter valued at approximately $128,000. 12.55% of the stock is currently owned by institutional investors and hedge funds.

Bonk Company Profile

(Get Free Report)

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.

Featured Articles

Receive News & Ratings for Bonk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bonk and related companies with MarketBeat.com's FREE daily email newsletter.